Publications by authors named "Dipanjan Chatterjee"
Article Synopsis
- Septic shock is a serious condition related to sepsis, and current treatments often yield poor outcomes, prompting the exploration of new therapies like CytoSorb, which shows potential for improvement.
- A consensus was created to guide the use of CytoSorb for septic shock treatment specifically in India, combining expert opinions and evidence from recent literature.
- After multiple rounds of voting, 11 experts reached agreement on nine key statements related to the use of CytoSorb, highlighting aspects like therapy timing, patient condition prerequisites, and treatment effectiveness.
Background: Initial reports from Wuhan (China) suggested poor outcomes for severe COVID-19 patients treated with Extracorporeal Membrane Oxygenation (ECMO). Extracorporeal Life Support Organization (ELSO) interim 2019 guidelines also recommended using ECMO only when all conventional therapies are exhausted. However, later studies showed that delayed ECMO initiation may lead to longer ECMO runs, offsetting any benefit from resource conservation by delaying the initiation.
View Article and Find Full Text PDFDiscontinuation of ECMO-a review with a note on Indian scenario.
Indian J Thorac Cardiovasc Surg
February 2023
Extracorporeal membrane oxygenation (ECMO) has strikingly progressed over the last 20 years in the management of adult and pediatric severe respiratory and cardiac dysfunctions refractory to conventional management. In this review, we will discuss the weaning strategies of veno-venous and veno-arterial ECMO including the bridge to recovery and bridge to transplant along with post-ECMO care. We will also discuss the futility and the management of bridge to nowhere from Indian perspectives.
View Article and Find Full Text PDF